Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes

Pulmonary Circulation

Volumn 3, Issue 1, 2013, Pages 5-19

  Forfia, Paul Robert ^a   Vaidya, Anjali ^a   Wiegers, Susan E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic respiratory disease; Cor pulmonale; Exercise physiology; Group 3 pulmonary hypertension; Pulmonary heart disease; Pulmonary hypertension; Pulmonary vascular disease; Right ventricular function; Ventilatory inefficiency

Indexed keywords

EID: 84901046626     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.109910     Document Type: Review

References (66)

1. Fishman AP. State of the art: Chronic cor pulmonale. Am Rev Respir Dis 1976;114:775-94.
2. Girgis RE, Mathai SC. Pulmonary hypertension associated with chronic respiratory disease. Clin Chest Med 2007;28:219-32, x.
3. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
4. Hughes JM, Glazier JB, Maloney JE, West JB. Effect of lung volume on the distribution of pulmonary blood flow in man. Respir Physiol 1968;4:58-72.
5. von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946;12:301-20.
6. Mark Evans A, Ward JP. Hypoxic pulmonary vasoconstriction-invited article. Adv Exp Med Biol 2009;648:351-60.
7. Naito T, Miyahara Y, Ikeda S. Ventilatory and pulmonary vascular responses to acute hypoxia are nonuniform in healthy man. Respiration 1995;62:185-9.
8. Weitzenblum E, Schrijen F, Mohan-Kumar T, Colas des Francs V, Lockhart A. Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest 1988;94:772-8.
9. Fishman AP, McClement J, Himmelstein A, Cournand A. Effects of acute anoxia on the circulation and respiration in patients with chronic pulmonary disease studied during the steady state. J Clin Invest 1952;31:770-81.
10. Bartsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation 2007;116:2191-202.
11. Weitzenblum E, Chaouat A. Cor pulmonale. Chron Respir Dis 2009;6:177-85.
12. Penaloza D, Sime F, Bachero N, Gamboa R. Pulmonary hypertension in healthy men born and living at high altitude. Med Thorac 1962;19:449-60.
13. Zielinski J, Tobiasz M, Hawrylkiewicz I, Sliwinski P, Palasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: A 6-year prospective study. Chest 1998;113:65-70.
14. Lloyd TC Jr. Influence of blood pH on hypoxic pulmonary vasoconstriction. J Appl Physiol 1966;21:358-64.
15. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996;109:380-6.
16. Harris P, Segel N, Green I, Housley E. The influence of the airways resistance and alveolar pressure on the pulmonary vascular resistance in chronic bronhcitis. Cardiovasc Res 1968;2:84-92.
17. Jardin F, Farcot JC, Boisante L, Prost JF, Gueret P, Bourdarias JP. Mechanism of paradoxic pulse in bronchial asthma. Circulation 1982;66:887-94.
18. Jellinek H, Krenn H, Oczenski W, Veit F, Schwarz S, Fitzgerald RD. Influence of positive airway pressure on the pressure gradient for venous return in humans. J Appl Physiol 2000;88:926-32.
19. The nature of flow of a fluid. In: Nichols WM, O’Rourke MF, editors. McDonald’s Blood Flow in Arteries. 3rd ed. Philadelphia, PA: Lea and Febiger; 1990. p. 12-53.
20. Hetzel M, Kochs M, Marx N, Woehrle H, Mobarak I, Hombach V, et al. Pulmonary hemodynamics in obstructive sleep apnea: Frequency and causes of pulmonary hypertension. Lung 2003;181:157-66.
21. O’Hearn DJ, Gold AR, Gold MS, Diggs P, Scharf SM. Lower extremity edema and pulmonary hypertension in morbidly obese patients with obstructive sleep apnea. Sleep Breath 2009;13:25-34.
22. Davidson D, Stalcup SA, Mellins RB. Systemic hemodynamics affecting cardiac output during hypocapnic and hypercapnic hypoxia. J Appl Physiol 1986;60:1230-6.
23. Marshall JM. Peripheral chemoreceptors and cardiovascular regulation. Physiol Rev 1994;74:543-94.
24. Stewart AG, Waterhouse JC, Billings CG, Baylis PH, Howard P. Hormonal, renal, and autonomic nerve factors involved in the excretion of sodium and water during dynamic salt and water loading in hypoxaemic chronic obstructive pulmonary disease. Thorax1995;50:838-45.
25. Campbell EJ, Short DS. The cause of oedema in ‘corpulmonale’. Lancet 1960;1:1184-6.
26. Anand IS, Chandrashekhar Y, Ferrari R, Sarma R, Guleria R, Jindal SK, et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 1992;86:12-21.
27. Baudouin SV. Oedema and cor pulmonale revisited. Thorax1997;52:401-2.
28. Mannix ET, Dowdeswell I, Carlone S, Palange P, Aronoff GR, Farber MO. The effect of oxygen on sodium excretion in hypoxemic patients with chronic obstructive lung disease. Chest 1990;97:840-4.
29. de Leeuw PW, Dees A. Fluid homeostasis in chronic obstructive lung disease. Eur Respir J Suppl 2003;46:33s-40s.
30. Golbin JM, Somers VK, Caples SM. Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc 2008;5:200-6.
31. Kerbaul F, Brimioulle S, Rondelet R, Dewachter C, Hubloue I, Naeije R. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 2007;175:846-50.
32. Kuehne T, Yilmaz S, Steendijk P, Moore P, Groenink M, Saaed M, et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: In vi vo validation and clinical application in patients with pulmonary hypertension. Circulation 2004;110:2010-6.
33. Butler J. The heart is not always in good hands. Chest 1990;97:453-60.
34. Settle HP Jr, Engel PJ, Fowler NO, Allen JM, Vassallo CL, Hackworth JN, et al. Echocardiographic study of the paradoxical arterial pulse in chronic obstructive lung disease. Circulation 1980;62:1297-1307.
35. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40.
36. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-21.
37. Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034-41.
38. Saxena N, Rajagopalan N, Edelman K, Lopez-Candales A. Tricuspid annular systolic velocity: A useful measurement in determining right ventricular systolic function regardless of pulmonary artery pressures. Echocardiography 2006;23:750-5.
39. Thabut G, Dauriat G, Stern JB, Logeart D, Levy A, Marrash-Chahla R, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005;127:1531-6.
40. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007;132:998-1006.
41. Nakatsuka M. Pulmonary vascular resistance and right ventricular function in morbid obesity in relation to gastric bypass surgery. J Clin Anesth 1996;8:205-9.
42. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008;32:1371-85.
43. Pynnaert C, Lamotte M, Naeije R. Aerobic exercise capacity in COPD patients with and without pulmonary hypertension. Respir Med 2010;104:121-6.
44. Cor Pulmonale. In: Paul Hamilton Wood, editor. Diseases of the Heart and Circulation. 3rd ed. London: Eyre and Spottiswoode; 1968. p. 986-1004.
45. Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, et al. Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension. Respirology 2011;16:451-8.
46. Glaser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 2009;103:317-24.
47. Vonbank K, Funk GC, Marzluf B, Burian B, Ziesche R, Stiebellehner L, et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien Klin Wochenschr 2008;120:749-55.
48. Naeije R, Huez S. Reflections on wave reflections in chronic thromboembolic pulmonary hypertension. Eur Heart J 2007;28:785-7.
49. Arkles JS, Opotowsky AR, Ojeda J, Rogers F, Liu T, Prassana V, et al. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 2011;183:268-76.
50. Prasanna V, Raina A, Arkles J, Opotowsky A, Kawut S, Akaya Smith K, et al. Echo-Doppler scoring system identifies ‘proportionate’ and ‘disproportionate’ pulmonary hypertension in patients with chronic left heart disease and respiratory disease. Am J Respir Crit Care Med 2011;183:A2294.
51. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:189-94.
52. Fartoukh M, Humbert M, Capron F, Maitre S, Parent F, Le Gall C, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000;161:216-23.
53. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: Epidemiology and clinical characteristics. Eur Respir J 2005;25:783-8.
54. Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006;54:184-91.
55. Saggar R, Shapiro SS, Ross DJ, Fishbein MC, Zisman DA, Lynch JP 3rd, et al. Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation. J Heart Lung Transplant 2009;28:964-7.
56. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1980;93:391-8.
57. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1:681-6.
58. Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 2007;175:846-50.
59. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104:429-35.
60. Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, et al. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 2008;32:619-28.
61. Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld- Wollbruck B, Grimminger F, et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis. Pneumologie 2000;54:133-42.
62. Han MK, Bach D, Hagan P, Schmidt SL, Flaherty KR, Toews GB, et al. Presence of right ventricular dysfunction modifies treatment response to sildenafil in the step-ipf trial [abstract]. Am J Respir Crit Care Med 2011; 183:A5301.
63. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 2002;360:895-900.
64. Dernaika TA, Beavin M, Kinasewitz GT. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease. Respiration 2010;79:377-82.
65. Mercurio V, Carlomagno G, Fazio S. Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: Case report and review of the literature. Heart Lung 2012;41:512-7.
66. Barnett CF, Bonura EJ, Nathan SD, Ahmad S, Shlobin OA, Osei K, et al. Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. Chest 2009;135:1455-61.